Redefining tryptase norms in the pediatric population reveals sex-based differences: Clinical implications

Allergy. 2024 Oct 19. doi: 10.1111/all.16365. Online ahead of print.

Mathilde Puel¹, Julien Rossignol^{2

3}, Clotilde Devin², Marine Madrange², Antoine Diep¹, Pascale Nicaise Roland¹, Sylvie Chollet-Martin¹, Julien Husson⁴, Olivier Hermine^{2

3}, Christine Bodemer^{2

5}, Chantal Brouzes⁶, Luc De Chaisemartin¹, Laura Polivka^{2

5}; CEREMAST network

¹ AP-HP, Immunology Laboratory, Bichat Hospital, Paris, France.
² CEREMAST, Imagine Institute, INSERM U1163, AP-HP, Necker-Children's Hospital, Paris Centre University, Paris, France.
³ Department of Hematology, AP-HP, Necker-Children's Hospital, Paris, France.
⁴ Data Science Platform, Imagine Institute, INSERM U1163, Paris Centre University, Paris, France.
⁵ AP-HP, Necker-Children's Hospital, Department of Dermatology, Reference Center for Genodermatoses (MAGEC), Paris Centre University, Paris, France.
⁶ AP-HP, Hematology Laboratory, Necker-Children's Hospital, Paris, France.

No abstract available

Keywords: hereditary alpha‐tryptasemia; mast cells; pediatric allergy; serum basal tryptase.

Publication types